<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139679">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02043782</url>
  </required_header>
  <id_info>
    <org_study_id>CP241</org_study_id>
    <nct_id>NCT02043782</nct_id>
  </id_info>
  <brief_title>Investigation of a New 1-piece Convex Ostomy Product</brief_title>
  <official_title>Investigation of a New 1-piece Convex Ostomy Product in Subjects With Ileostomy and Colostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the investigation was to investigate the performance and safety of a new ostomy
      product
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Degree of leakage</measure>
    <time_frame>14 +/- 3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The degree of leakage is investigated on a 33-point scale</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Stoma Ileostomy</condition>
  <condition>Stoma Colostomy</condition>
  <arm_group>
    <arm_group_label>First Coloplast Test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods.
First subjects are allocated to Coloplast Test; Secondly to either
Own product (baseline)
Competitor soft convex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Competitor soft convex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods.
First subjects are allocated to Competitor soft convex; Secondly to either
Own product (baseline)
Coloplast Test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Own product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects are randomised 1:1:1 into six possible treatment groups to ensure random allocation of the treatments to the periods.
First subjects are allocated to Own product; Secondly to either
Coloplast Test
Competitor soft convex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test</intervention_name>
    <description>Newly developed 1 -piece convex ostomy product</description>
    <arm_group_label>First Coloplast Test</arm_group_label>
    <arm_group_label>First Competitor soft convex</arm_group_label>
    <arm_group_label>First Own product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Own product</intervention_name>
    <description>The subjects Own product is used as baseline performance in this investigation. The products are commercial and available on the market and are products manufactured by manufactures who produce convex ostomy products ie  Coloplast, Convatec, Dansac, B.Braun, Hollister and  more.</description>
    <arm_group_label>First Coloplast Test</arm_group_label>
    <arm_group_label>First Competitor soft convex</arm_group_label>
    <arm_group_label>First Own product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Competitor soft convex</intervention_name>
    <description>A commercially available soft convex product</description>
    <arm_group_label>First Coloplast Test</arm_group_label>
    <arm_group_label>First Competitor soft convex</arm_group_label>
    <arm_group_label>First Own product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are at least 18 years of age and have full legal capacity.

          -  Have had an ileostomy/colostomy for more than 3 months

          -  Have used a 1-piece flat ostomy product for the last 1 month

          -  Has given written Informed Consent and signed the letter of authority

          -  Have an ileostomy or colostomy with a diameter of 33 mm or less

          -  Has experienced leakage (seeping) under the baseplate at least three     times during
             the last two weeks

          -  Are evaluated to be suitable for a soft convex product

          -  If having a colostomy: changes their product on average 2 times pr. 24h or more

          -  Currently uses a bag of size medi/midi or maxi

        Exclusion Criteria:

          -  Have a loop ostomy (also called double-barrel or ostomy with two outlets).

          -  Are pregnant or breastfeeding

          -  Currently receiving or have within the past 2 month received radio- and/or
             chemotherapy

          -  Currently receiving or have within the past month received systemic or local steroid
             treatment in the peristomal area

          -  Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).

          -  Known hypersensitivity toward any of the test products

          -  Participating in other interventional clinical investigations or have previously
             participated in this investigation

          -  Use irrigation during the investigation (flush the intestine with water)

          -  Have a fistula in the peristomal area or less than 2 cm from the edge of the
             baseplate

          -  If subject has a colostomy: empties the bag
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birte P Jakobsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coloplast A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>TFS</name>
      <address>
        <city>SÃ¸borg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>April 27, 2014</lastchanged_date>
  <firstreceived_date>January 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
